chr16-763660-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_005823.6(MSLN):c.148G>A(p.Gly50Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000441 in 1,586,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_005823.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MSLN | NM_005823.6 | c.148G>A | p.Gly50Arg | missense_variant | 5/18 | ENST00000545450.7 | NP_005814.2 | |
MSLN | NM_013404.4 | c.148G>A | p.Gly50Arg | missense_variant | 4/17 | NP_037536.2 | ||
MSLN | NM_001177355.3 | c.148G>A | p.Gly50Arg | missense_variant | 5/18 | NP_001170826.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MSLN | ENST00000545450.7 | c.148G>A | p.Gly50Arg | missense_variant | 5/18 | 1 | NM_005823.6 | ENSP00000442965.2 |
Frequencies
GnomAD3 genomes AF: 0.00000706 AC: 1AN: 141708Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000415 AC: 6AN: 1444866Hom.: 0 Cov.: 33 AF XY: 0.00000418 AC XY: 3AN XY: 717100
GnomAD4 genome AF: 0.00000706 AC: 1AN: 141708Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 68682
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2024 | The c.148G>A (p.G50R) alteration is located in exon 4 (coding exon 3) of the MSLN gene. This alteration results from a G to A substitution at nucleotide position 148, causing the glycine (G) at amino acid position 50 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at